Strong global surveillance systems and the absence of any novel pathogen demonstrating sustained human-to-human transmission capable of worldwide spread underpin the market's 84.5% implied probability against a new pandemic before 2028. As of September 2026, SARS-CoV-2 activity remains low globally with Omicron sublineages dominating and test positivity trending downward, while confirmed outbreaks such as Bundibugyo Ebola in the Democratic Republic of the Congo and Uganda stay regionally contained despite rapid initial growth. Historical patterns show major viral pandemics occurring at median intervals of roughly 13 years since 1900, and current epidemiological data indicate no immediate crossover from zoonotic or vector-borne threats like Marburg, Nipah, or avian influenza to pandemic scale. Traders weigh enhanced post-COVID monitoring and early detection against rising spillover risks from climate and conflict, but near-term model consensus and case thresholds favor containment through the end of 2027.